Jurgen Eck

The supplied stub identifies Jurgen Eck as a Senior Investment Manager associated with BOM. I could not independently verify a current BOM staff listing, current title, LinkedIn profile, headshot, or person-specific email for Jurgen Eck from public sources. BOM’s current public staff page does not show a Jurgen Eck entry among listed employees.

BOM, the Brabantse Ontwikkelings Maatschappij, is a public implementation organization founded in 1983 by the Province of North Brabant and the Dutch Ministry of Economic Affairs, which remain its shareholders. BOM says it supports entrepreneurs with capital, expertise, and a global network, combining ecosystem development, investing, and internationalization.

BOM describes itself as one of the most active startup investors in the Netherlands, investing with its own funds and alongside more than 150 co-investors. Its investment activity is aimed at scalable startups and scale-ups with a strong Brabant link, using patient public capital, sector expertise, and venture development programs.

• BOM invests in “schaalbare start- en scale-ups met groeipotentie en een sterke link met Brabant” — scalable startups and scale-ups with growth potential and a strong link to Brabant.
• Check sizes are €200,000 to €5 million; BOM states that it takes minority positions only, with ownership never above 49%.
• BOM’s stated investment horizon is 3 to 7 years, and it targets market-conform returns.
• Key Technologies focus: deeptech and AI-Tech, including fundamental hardware, low-level software, AI infrastructure and application-layer products, and scalable, defensible product companies.
• Climate Tech focus: decentralized and renewable energy, plant-based solutions, circular-economy models, CO2 reduction, and energy-transition ventures.
• Medtech & Life Sciences focus: medical devices, diagnostics, therapies, and healthtech products that make care more accessible.
• BOM emphasizes patient capital plus active support: venture development programs, hands-on guidance, market validation, product development, partner mobilization, and access to co-investors.